Visalytics
Visalytics
approved EB-2 (NIW)

Graduate Student

Biomedical Science · Poland · 2022-01-10

Processing Time
290 days
Decision Date
2022-01-10
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical issues in cancer treatment and has received funding from major agencies like the NIH.

2 Well-positioned to Advance the Endeavor Met

The petitioner has an MS in Biotechnology and a strong record of 5 publications and 165 citations.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's contributions to cancer research are of such value that they benefit the United States to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 5 peer-reviewed journal articles with 165 citations and support from 4 expert letters. Her work received significant funding from the National Institutes of Health (NIH) and the European Union, satisfying the Dhanasar prongs for national importance and being well-positioned.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Original Contributions
Government Alignment

Similar Cases

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Postdoctoral Researcher

Research and Development · India

WeGreened EB-2 (NIW) approved
New Jersey 173 days 2022-04-11
The petitioner proposes to systematically characterize genes and pathways involved in cancer development and progression using laboratory-based and animal models to study biological and clinical phenotypes. This work aims to identify novel molecular targets for cancer diagnosis, prognosis, and treatment modalities, specifically focusing on advanced breast cancer.
View Case

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 289 days 2025-02-26
The petitioner proposes to continue her research in biotechnology, specifically developing novel combinatorial chemotherapies, immunotherapies, and plasma-based prognostic markers for cancer treatment. Her work focuses on investigating cancer signaling pathways and immune checkpoint regulation to enhance therapeutic efficacy and support personalized oncology care.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Pennsylvania 162 days 2022-07-19
The petitioner proposes to continue her research in molecular and cellular cancer biology, cancer chemotherapy, and inflammation. Her work focuses on fundamentally transforming cancer biology research and developing improved treatments for cancer to address the national and global health burden of the disease.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Poland

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-01-10.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 290 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Poland All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist